New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
07:07 EDTAGN, VRX, MSAllergan: Executives from Morgan Stanley recently sent emails to management
Allergan (AGN) says executives from Morgan Stanley (MS), the investment bank understood to have recently been retained by Valeant (VRX), have sent emails directly to Allerganís management team that suggest they share the concerns of Allergan and third parties.
News For AGN;VRX;MS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 8, 2014
16:10 EDTAGNAllergan initiated with a Buy at Deutsche Bank
Subscribe for More Information
08:42 EDTAGNSalix shares should be bought on weakness, says Sterne Agee
After Reuters yesterday afternoon reported that Actavis (ACT) plans to make a new merger approach to Allergan (AGN), Sterne Agee believes that Salix's standalone value is $162. The firm expects the shares to reach that level following approval of its Xifaxan IBS-D drug after the February 2015 PDUFA date.
07:20 EDTMSCapital Link to hold a forum
Subscribe for More Information
07:19 EDTAGNCBI to hold a conference
Subscribe for More Information
07:13 EDTMSBank dealers agree to revised derivatives rules, FT reports
Subscribe for More Information
06:56 EDTMSBarclays lists several Large-Cap banks with the most Q3 upside
Subscribe for More Information
06:23 EDTVRX, AGNActavis more inclined to pursue Allergan over Salix, says Citigroup
Subscribe for More Information
October 7, 2014
18:29 EDTAGN, VRXOn The Fly: After Hours Movers
Subscribe for More Information
18:05 EDTAGN, VRXValeant, Pershing Square plan to raise Allergan bid by $15 a share, WSJ says
Subscribe for More Information
17:52 EDTAGN, VRXAllergan up 2.8% after Dow Jones says Valeant planning to boost bid for company
17:49 EDTAGN, VRXValeant up 3.9% after Dow Jones says planning to boost Allergan bid
Subscribe for More Information
17:47 EDTVRX, AGNValeant, Pershing Square planning to boost Allergan bid by $15 a share, DJ says
Subscribe for More Information
15:21 EDTAGN, VRXAllergan warms to sale as Actavis plans new approach, Reuters says
Subscribe for More Information
15:01 EDTAGNAllergan up 1.5% following report on Actavis planned approach on merger
14:59 EDTAGNActavis plans new approach to Allergan, Reuters reports
Subscribe for More Information
09:17 EDTMSSecurities Industry & Financial Markets Association to hold a conference
Subscribe for More Information
07:48 EDTAGNSalix reinstated with a Buy at Jefferies
Subscribe for More Information
07:28 EDTMSWells Fargo ups price target ranges for capital markets banks
Subscribe for More Information
07:12 EDTVRX, AGNAllergan requests Ackman be hindered from voting at meeting, Bloomberg says
In an effort to avoid an unsolicited $54B acquisition offer from Valeant Pharmaceuticals (VRX), Allergan (AGN) filed a request in a California court for a judge to hinder Bill Ackmanís Pershing Square from voting its 10% stake at the December shareholder meeting, according to Bloomberg, citing the filing. A hearing regarding Allergan's request is set to occur on October 28. Reference Link
06:51 EDTMSJustice Department set to attack more large banks by year end, NY Times says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use